tradingkey.logo

0.000
Close ETQuotes delayed by 15 min
--Market Cap
--P/E TTM

0.000
More Details of Bio Rad Laboratories Inc Company
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Company Info
Ticker SymbolBIOb
Company nameBio Rad Laboratories Inc
IPO dateMar 17, 1980
Founded at1975
CEOMr. Norman D. Schwartz
Number of employees7700
Security type- -
Fiscal year-endMar 17
Address1000 Alfred Nobel Dr
CityHERCULES
Stock exchange- -
CountryUnited States of America
Postal code94547
Phone15107247000
Websitehttps://www.bio-rad.com/
Ticker SymbolBIOb
IPO dateMar 17, 1980
Founded at1975
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
374.47K
+0.03%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
374.47K
+0.03%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Jonathan P. (Jon) Divincenzo
Mr. Jonathan P. (Jon) Divincenzo
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Mr. Michael Crowley
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
1.04B
40.58%
Europe
834.10M
32.50%
APAC
521.60M
20.32%
Other
169.30M
6.60%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Apr 2
Updated: Wed, Apr 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.08%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
7.39%
Schwartz (Alice N)
1.12%
Schwartz (Steven D)
0.75%
Other
2.03%
Shareholders
Shareholders
Proportion
Blue Raven Partners, L.P.
80.08%
Alice N. Schwartz Revocable Trust
8.63%
Schwartz (Norman D)
7.39%
Schwartz (Alice N)
1.12%
Schwartz (Steven D)
0.75%
Other
2.03%
Shareholder Types
Shareholders
Proportion
Corporation
88.71%
Individual Investor
9.34%
Investment Advisor
0.05%
Other
1.90%
Institutional Shareholding
Updated: Wed, Mar 12
Updated: Wed, Mar 12
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
24
4.98M
98.13%
-2.53K
2024Q4
24
4.98M
98.13%
-2.55K
2024Q3
23
4.98M
98.13%
-1.92K
2024Q2
24
4.97M
98.11%
-3.25K
2024Q1
25
4.98M
98.12%
-3.79K
2023Q4
26
4.98M
98.03%
-84.86K
2023Q3
26
4.96M
97.77%
-85.38K
2023Q2
26
4.95M
97.50%
-98.97K
2023Q1
28
4.95M
97.51%
-104.93K
2022Q4
27
4.95M
97.55%
-162.05K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Blue Raven Partners, L.P.
4.06M
80.07%
--
--
Feb 24, 2025
Alice N. Schwartz Revocable Trust
437.51K
8.63%
-342.00
-0.08%
Feb 24, 2025
Schwartz (Norman D)
374.47K
7.39%
+114.00
+0.03%
Feb 24, 2025
Schwartz (Alice N)
57.00K
1.12%
--
--
Feb 24, 2025
Schwartz (Steven D)
38.24K
0.75%
+57.00
+0.15%
Feb 24, 2025
Allison (Schwartz)
4.00K
0.08%
+57.00
+1.45%
Feb 24, 2025
CSS, LLC
1.34K
0.03%
-151.00
-10.12%
Dec 31, 2024
Buckingham Strategic Wealth, LLC
760.00
0.01%
--
--
Jun 30, 2024
Morgan Stanley Smith Barney LLC
692.00
0.01%
--
--
Dec 31, 2024
Wells Fargo Advisors
170.00
0%
--
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI